Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUFFIN: n-3 PUFA Supplementation in N-ERD and Uncontrolled Asthma
NCT05613803Phase 3Completed
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Start
- Oct 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and airway disease comparing Fish oil with Placebo (2 arms). Primary endpoint: Asthma Control Questionnaire 6 at 24 weeks. Started Oct 2023; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
asthmaairway disease
Beyond the preview
Go deeper on NCT05613803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05613803.